Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-11-21

FDA Approved: OXYCODONE AND ASPIRIN — Supplemental Application (Epic Pharma, LLC)

View source ↗

Summary

FDA approved a supplemental application for the Oxycodone and aspirin combination analgesic from Epic Pharma, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxycodone and aspirin (Oxycodone/aspirin)

Snippet

SUPPL AP for OXYCODONE AND ASPIRIN (OXYCODONE AND ASPIRIN)